[go: up one dir, main page]

Zang et al., 2018 - Google Patents

Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index

Zang et al., 2018

View PDF
Document ID
7936336667071775984
Author
Zang H
Jiang F
Cheng X
Xu H
Hu X
Publication year
Publication venue
Endocrine journal

External Links

Snippet

Adropin has been identified as potent regulatory hormone implicated in insulin sensitivity and the maintenance of energy homeostasis. The aim of current study was to investigate serum adropin concentrations of type 2 diabetes mellitus (T2DM) patients in the fasting …
Continue reading at www.jstage.jst.go.jp (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/41Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/412Detecting or monitoring sepsis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

Similar Documents

Publication Publication Date Title
Zang et al. Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index
Jones et al. Plasma lactate as a marker of metabolic health: Implications of elevated lactate for impairment of aerobic metabolism in the metabolic syndrome
Wang et al. Serum levels of meteorin-like (Metrnl) are increased in patients with newly diagnosed type 2 diabetes mellitus and are associated with insulin resistance
Lee et al. Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults
Simon et al. Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis
Leehey et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study
Suleymanoglu et al. Vaspin and its correlation with insulin sensitivity indices in obese children
Obata et al. Relationship between serum adiponectin levels and age in healthy subjects and patients with type 2 diabetes
Xu et al. Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese
Yan et al. Decreased plasma neuregulin 4 levels are associated with peripheral neuropathy in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study
Sente et al. Tumor necrosis factor-α impairs adiponectin signalling, mitochondrial biogenesis, and myogenesis in primary human myotubes cultures
Wlazlo et al. Low-grade inflammation and insulin resistance independently explain substantial parts of the association between body fat and serum C3: the CODAM study
Huang et al. Insulin resistance, hyperglycemia, and risk of developing obstructive sleep apnea in men and women in the United States
Onalan et al. Low serum levels of meteorin-like/subfatin: an indicator of diabetes mellitus and insulin resistance?
Moesgaard et al. Effects of breed, gender, exercise and white-coat effect on markers of endothelial function in dogs
Polat et al. The relationship between frailty and serum alpha klotho levels in geriatric patients
Banu et al. C-peptide and its correlation to parameters of insulin resistance in the metabolic syndrome
Mancuso et al. Effects of Alpha-2-HS-glycoprotein on cognitive and emotional assessment in prediabetic and diabetic subjects
Taner et al. The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus
Xu et al. Serum advanced glycation end products are associated with insulin resistance in male nondiabetic patients with obstructive sleep apnea
Meral et al. New adipocytokines (vaspin, apelin, visfatin, adiponectin) levels in children treated with valproic acid
Chuang et al. The relationships between hematogram and metabolic syndrome in elderly subgroups: a Taiwan cohort study
Uzunlulu et al. Cut-off values for waist circumference in Turkish population: is there a threshold to predict insulin resistance
Hong et al. The effect of physical activity on serum IL-6 and vaspin levels in late elementary school children
US7592180B2 (en) Method for evaluating insulin resistance